AU - zour - Kwan, AU - Ho - Chan，姚佩忠，AU - Wong, Samuel Yeung-shan AU - Lee, Shui Shan PY - 2023 DA - 2023/4/26 TI -基于社交网络的男男性行为者HIV自我检测方法的实施级联:横断面研究乔- J地中海互联网Res SP - e46514六世- 25 KW -社区测试服务KW -横断面研究KW -艾滋病自测KW -艾滋病毒检测KW - HIV千瓦级联实现千瓦——与男性发生性关系的男性KW -社交网络KW -病毒传播AB -背景:艾滋病毒检测是实现快速目标战略的基石,结束了2030年艾滋病流行。自我测试已被证明是男男性行为者(MSM)的有效健康干预措施。虽然世界卫生组织建议使用基于社会网络的方法分发艾滋病毒自我检测，但其实施包括多个步骤，需要进行适当评估。目的:本研究旨在评估基于社交网络的艾滋病自我检测方法在香港对从未接受过检测的男同性恋者的实施级联性。方法:这是一个横断面研究。种子MSM参与者是通过不同的网络渠道招募的，他们又邀请他们的同龄人参加这项研究。设立了一个网络平台，以支持招聘和转介程序。在完成一份自我管理的问卷后，参与者可以要求进行口服液或手指刺破艾滋病毒自检，有或没有实时支持。在上传测试结果并通过网络培训后，可进行转介。 Characteristics of participants completing each of these steps and their preferences for the type of HIV self-test were evaluated. Results: A total of 463 MSM were recruited, including 150 seeds. Participants recruited by seeds were less likely to have previously been tested for HIV (odds ratio [OR] 1.80, 95% CI 1.06-3.04, P=.03) and have lower confidence in performing self-tests (OR 0.66, 95% CI 0.45-0.99, P=.045). Almost all (434/442, 98%) MSM who completed the questionnaire requested a self-test, of whom 82% (354/434) had uploaded their test results. Participants requesting support were new to self-testing (OR 3.65, 95% CI 2.10-6.35, P<.001) and less confident in carrying out the self-test correctly (OR 0.35, 95% CI 0.22-0.56, P<.001). More than half (216/354, 61%) of the eligible participants initiated the referral process by attempting the web-based training with a passing rate of 93% (200/216). They were more likely to have sought sex partners (OR 2.20, 95% CI 1.14-4.25, P=.02), especially through location-based networking apps (OR 2.13, 95% CI 1.31-3.49, P=.002). They also gave higher usability scores along the implementation cascade (median 81 vs 75, P=.003). Conclusions: The social network approach was effective in diffusing HIV self-tests in the MSM community and reaching nontesters. Support and option to choose a preferable type of self-test are essential to address users’ individual needs when delivering HIV self-tests. A positive user experience throughout the processes along the implementation cascade is vital to transform a tester into a promoter. Trial Registration: ClinicalTrials.gov NCT04379206; https://clinicaltrials.gov/ct2/show/NCT04379206 SN - 1438-8871 UR - //www.mybigtv.com/2023/1/e46514 UR - https://doi.org/10.2196/46514 UR - http://www.ncbi.nlm.nih.gov/pubmed/37099364 DO - 10.2196/46514 ID - info:doi/10.2196/46514 ER -